Αποτελέσματα Αναζήτησης
10 Ιαν 2024 · The purpose of this guideline is to provide expert guidance on the systemic treatment of metastatic breast cancer (MBC) to clinicians, public health leaders, patients, and policymakers in resource-constrained settings.
Topics for guidelines are selected on the basis of significant clinical or economic importance; presence of variations in patterns of, or access to, care; availability of suitable data; and ethical considerations. Breast Cancer. Gastrointestinal Cancer.
You can also access ASCO guidelines with the tap of your finger via our app, pocket cards, and podcast: Download the free ASCO Guidelines App for iPhone/iPad or Android. Access ASCO Guideline Pocket Cards, members are eligible to receive free digital access.
10 Ιαν 2024 · This resource-stratified guideline and related ASCO guidelines present treatment for patients with these diagnoses, when quality-assured pathology results are available to guide the selection of targeted therapy, which are not yet available in many Basic and Limited Settings.
This clinical practice guideline provides recommendations on the follow-up and management of asymptomatic patients with breast cancer who have completed primary therapy with curative intent. The guideline was originally published in 1997 and updated in 1999 and 2006.
19 Οκτ 2021 · This ESMO Clinical Practice Guideline provides key recommendations and algorithms for managing metastatic breast cancer. •. It covers diagnosis, staging, risk assessment, treatment, disease monitoring, palliative care and the patient perspective. •. ESMO-MCBS and ESCAT scores are given to describe the levels of evidence for treatment choices. •.
3 Απρ 2020 · Providers caring for patients with breast cancer with germline BRCA1/2 mutations should discuss treatment options related to the index cancer and the increased risk of contralateral breast cancer (CBC) and new ipsilateral breast cancer.
